Vaxcyte, Inc. PCVX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s operating lease liabilities?
- Vaxcyte, Inc. (PCVX) reported operating lease liabilities of $110.21M in Q1 2026.
- How has Vaxcyte, Inc.'s operating lease liabilities changed year-over-year?
- Vaxcyte, Inc.'s operating lease liabilities increased by 35.9% year-over-year, from $81.08M to $110.21M.
- What is the long-term trend for Vaxcyte, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s operating lease liabilities has grown at a 76.4% compound annual growth rate (CAGR), from $11.51M to $111.46M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.